GPT-Rosalind (OpenAI) vs Grok Speech (STT + TTS APIs)

Which one should you pick? Here's the full breakdown.

GPT-Rosalind (OpenAI)

C
6.8/10

OpenAI's first domain-specific model -- life sciences, drug discovery, translational medicine. Launched 2026-04-16 as a Trusted Access research preview. Launch partners: Amgen, Moderna, Allen Institute, Thermo Fisher. Paired with a Life Sciences Codex plugin (50+ scientific tool integrations)

Our Pick

Grok Speech (STT + TTS APIs)

A
8.1/10

xAI's standalone voice APIs -- launched 2026-04-17. Built on the stack that powers Grok Voice, Tesla vehicles, and Starlink customer support. $0.10/hr STT batch, $4.20 per 1M characters TTS, 25+ languages, word-level timestamps + speaker diarization

CategoryGPT-Rosalind (OpenAI)Grok Speech (STT + TTS APIs)
Ease of Use3.07.0
Output Quality9.08.5
Value7.09.0
Features8.08.0
Overall6.88.1

Pricing Comparison

FeatureGPT-Rosalind (OpenAI)Grok Speech (STT + TTS APIs)
Free TierNoNo
Starting PriceInvite only$0.10

Which Should You Pick?

Pick GPT-Rosalind (OpenAI) if...

Researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get Trusted Access. Also relevant to anyone building life-sciences AI products who needs to understand where OpenAI's vertical strategy is heading.

Visit GPT-Rosalind (OpenAI)

Pick Grok Speech (STT + TTS APIs) if...

  • Easier to use (7 vs 3)
  • Better value for money (9/10)

Developers building voice agents, real-time transcription tools, accessibility features, or high-volume TTS workloads where the cost per hour of audio actually matters at scale. Strong fit for phone-call and meeting transcription use cases where xAI's published WER advantage (5.0% on phone-call entities vs. ElevenLabs 12.0%) compounds quickly.

Visit Grok Speech (STT + TTS APIs)

Our Verdict

Grok Speech (STT + TTS APIs) is the clear winner here with 8.1/10 vs 6.8/10. GPT-Rosalind (OpenAI) isn't bad, but Grok Speech (STT + TTS APIs) outperforms it across the board. Pick GPT-Rosalind (OpenAI) only if researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get trusted access.